[Advance in the treatment of postmenopausal osteoporosis].
Akazawa
Kenji
K
Department of Gynecology, Tokyo Metropolitan Tama Geriatric Hospital.
D000368:Aged; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000652:urine; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D010446:Peptide Fragments / Q000652:urine; D011347:Procollagen / Q000652:urine; D011788:Quality of Life; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D000596:Amino Acids; D015415:Biomarkers; D004164:Diphosphonates; D010446:Peptide Fragments; D011347:Procollagen; D020845:Selective Estrogen Receptor Modulators; C047202:procollagen Type I N-terminal peptide; D020849:Raloxifene Hydrochloride; C036020:deoxypyridinoline